Literature DB >> 35507497

Pembrolizumab in Early Triple-Negative Breast Cancer.

Shuvadeep Ganguly1, Ajay Gogia1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35507497     DOI： 10.1056/NEJMc2203316

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  1 in total

1.  Investigation of the efficacy and safety of cryoablation and intra-arterial PD-1 inhibitor in patients with advanced disease not responding to checkpoint inhibitors: An exploratory study.

Authors:  Fuqun Wei; Rui Guo; Yuan Yan; Ruixiang Lin; Jin Chen; Zhengyu Lin
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.